top of page
NextGen Exteriors -29.jpg

Advancing
Neuro-Muscular
Health

Neuro-Muscular Labs, where the hyphen is intentional. Our research bridges the nervous and muscular systems, advancing discoveries from molecular mechanisms to clinical therapies. Explore how our labs push the boundaries of science to improve human health

Arnold Lab.png

Advancing
Neuro-Muscular
Health

Neuro-Muscular Labs, where the hyphen is intentional. Our research bridges the nervous and muscular systems, advancing discoveries from molecular mechanisms to clinical therapies. Explore how our labs push the boundaries of science to improve human health

Lab Wideview.jpeg

Advancing
Neuro-Muscular
Health

Neuro-Muscular Labs, where the hyphen is intentional. Our research bridges the nervous and muscular systems, advancing discoveries from molecular mechanisms to clinical therapies. Explore how our labs push the boundaries of science to improve human health

231113 Society for Neuroscience - Washington DC Day 3 - P1041946-Enhanced-NR_edit (1) (1).

Advancing
Neuro-Muscular
Health

Neuro-Muscular Labs, where the hyphen is intentional. Our research bridges the nervous and muscular systems, advancing discoveries from molecular mechanisms to clinical therapies. Explore how our labs push the boundaries of science to improve human health

   Neuro-Muscular Labs (NML) is a collaborative neuroscience research collective located within the Roy Blunt NextGen Precision Health building at the University of Missouri. Our laboratories integrate expertise in molecular biology, cellular neuroscience, electrophysiology, advanced imaging, rehabilitation science and translational medicine to study diseases affecting the nervous and muscular systems.

   Our research spans a broad range of neuromuscular, neurodevelopmental and neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS), Charcot-Marie-Tooth disease (CMT), myotonic dystrophy (DM), myasthenia gravis (MG), sarcopenia and disorders impacting cognition, learning and memory. Across these conditions, we investigate how dysfunction within nerves, myelin, motor neurons, muscles and synapses drives disease progression and disability.

   To address these questions, our teams utilize advanced experimental approaches including super-resolution microscopy, quantitative electrophysiology, molecular profiling, human biospecimen analysis, behavioral phenotyping and preclinical disease models. We also focus on translational therapeutic development, including precision medicine strategies.

   A defining strength of NML is our highly collaborative and interdisciplinary environment. By sharing expertise, technologies and scientific perspectives across laboratories, we accelerate discovery while training the next generation of neuroscientists and physician-scientists committed to improving outcomes for individuals living with neurological and neuromuscular disease.

See More
K Moss JPNS Image

Advanced Imaging

SFEMG-2l7md6r-1024x562-Crp.jpg

Functional Physiology

Untitled-4.png

Cellular Disease Modeling

#5 - 135 WT Sciatic-01_Fig Image.jpg

Precision Therapeutics

Sunset

W. David Arnold, MD

Professor and NextGen Executive Director

Translational Neuromuscular Physiology

Sunset

Smita Saxena, PhD

Professor

Neuronal and Circuit Vulnerability in Disease

Sunset

Hiroshi Nishimune, PhD

Professor

NMJ Development and Degeneration

Sunset

Ryan Castoro, DO

Assistant Professor

Proprioception and Peripheral Nerve Aging

Sunset

Bornali Kundu, MD, PhD

Assistant Professor

Memory Networks and Brain Stimulation

Sunset

Curtis Nutter, PhD

Assistant Professor

RNA Regulation in Neuromuscular Disease

Sunset

Kathryn Moss, PhD

Assistant Professor

Dysmyelinating Neuropathy Mechanisms

Sunset

Andrea Sierra Delgado, MD

Assistant Research Professor

Gene Therapy for Rare Neurological Disease

Sunset

Kristina Kelly, DPT

Assistant Research Professor

Weakness and Fatigue in Aging and Disease

Sunset

Ignaseclant Shows Promise in CMT

News & Media

Apr 14, 2026

News coverage featuring work from the laboratory of Dr. Arnold was featured in Show Me Mizzou: "Mizzou's bench-to-bedside efforts support a new drug for a neuromuscular disorder with no cure."

Sunset

Provisional Patent Filed for Therapeutic Strategy

News & Media

Apr 6, 2026

A provisional patent was filed by the laboratories of Dr. Arnold and Dr. Castoro for translational strategies targeting age-related functional decline.

See More>>>
Sunset

Burst Dynamics Enable Human Working Memory

Publications, Trainee Highlights

Mar 16, 2026

Research from the laboratory of Dr. Kundu, led by Vladimir Omelyusik, was published in NeuroImage: "Frontotemporal bursting supports human working memory".

Sunset

AAV9 Micro-Dystrophin Shows Therapeutic Promise

Publications

Mar 12, 2026

Research from the laboratory of Dr. Arnold was published in Molecular Therapy Advances: “Preclinical evaluation of INS1201 AAV9-micro-dystrophin via CSF administration as a potential therapy for Duchenne muscular dystrophy”.

Sunset

Thermosensory Deficits Across Neuropathy Models

Publications, Trainee Highlights

Mar 1, 2026

Research from the laboratory of Dr. Castoro, led by Dr. Vaibhav Oberoi and in collaboration with Dr. Arnold, Dr. Moss and Dr. Saxena, was published in the Journal of the Peripheral Nervous System: “Behavioral thermoceptive responses and morphologic correlates in mouse models of CMT1A, HNPP, and aging”

Sunset

2026 NextGen Pathways Conference

The NextGen Pathways Conference brought together faculty, trainees and leaders across the University of Missouri system to highlight innovation and foster collaboration.

Sunset

2026 Columbia Young Scientist Expo

NML researchers volunteered at Columbia Young Scientists Fair and Expo to engage local students and families in neuroscience and biomedical research.

Sunset

2025 Society for Neuroscience Meeting

NML members and the broader University of Missouri neuroscience community attended the annual SfN meeting to present research, lead minisymposia and connect with colleagues.

Sunset

2025 Walk to Defeat ALS

NML members participated in this annual fundraising event to support the ALS Association, raise awareness for ALS, and help provide hope, advocacy and support for patients and families.

NextGen_edited.jpg
Neuro-Muscular Labs Logo_V2_edited.png
Arnold Lab_edited.jpg
Castoro Lab_edited.jpg
Moss_Logo_edited.jpg

Want to join us?

bottom of page